Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexes. Blood , 2024; 144 (25): 2666 DOI: 10.1182/blood.2024025093 Cite This Page : ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...